BioLife Solutions Inc (BLFS)
Return on total capital
| Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | ||
|---|---|---|---|---|---|---|
| Earnings before interest and tax (EBIT) | US$ in thousands | -70,825 | -145,541 | -35,160 | -6,241 | -3,193 |
| Long-term debt | US$ in thousands | 18,311 | 23,793 | 6,353 | 655 | — |
| Total stockholders’ equity | US$ in thousands | 337,663 | 364,188 | 478,047 | 204,429 | 43,321 |
| Return on total capital | -19.90% | -37.51% | -7.26% | -3.04% | -7.37% |
December 31, 2023 calculation
Return on total capital = EBIT ÷ (Long-term debt + Total stockholders’ equity)
= $-70,825K ÷ ($18,311K + $337,663K)
= -19.90%
BioLife Solutions Inc's return on total capital has varied over the past five years, with negative figures recorded in each year. The return on total capital was at its lowest in 2022 at -37.51%, indicating a significant loss relative to the invested capital. This was followed by an improvement in 2023, but the figure remained negative at -19.90%. The company's performance in utilizing its total capital to generate profits has not been optimal, as seen in the negative returns across multiple years. This suggests that BioLife Solutions Inc may be facing challenges in efficiently deploying its capital to generate returns for its investors.
Peer comparison
Dec 31, 2023